Metabolic Study of Concentric and Eccentric Muscle Training
Launched by VORARLBERG INSTITUTE FOR VASCULAR INVESTIGATION AND TREATMENT · Oct 10, 2006
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
Physical exercise decreases the risk of obesity, diabetes mellitus, and cardiovascular disease. Skeletal muscle can be exercised by two ways: Concentric contraction is defined as active shortening of muscles, e.g. by stepping upwards, whereas eccentric muscle contraction is defined as active resistance to stretching, e.g. by stepping downwards. Although the effects of exercise (i.e. the combination of concentric and eccentric muscle contraction) on metabolic parameters have been extensively investigated, there are no data on the specific metabolic effects of concentric versus those of eccen...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy men and women
- • age over 30 years
- Exclusion Criteria:
- • previous systematic endurance training (≥3 times per week ≥30 min)
- • body mass index \>30 kg/m2
- • heavy smoking (\>20 cigarettes per day)
- • regular alcohol consumption \>60g per day
- • established musculoskeletal disease
- • history of cardiovascular disease
- • diabetes mellitus
- • unwillingness to stay in the area for the whole study period
About Vorarlberg Institute For Vascular Investigation And Treatment
The Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) is a leading clinical research organization dedicated to advancing the understanding and treatment of vascular diseases. Located in Vorarlberg, Austria, VIVIT specializes in the design and execution of innovative clinical trials, focusing on improving patient outcomes through cutting-edge research and collaborative partnerships. With a commitment to scientific excellence and patient safety, VIVIT aims to develop novel therapeutic strategies and enhance clinical practices in the field of vascular medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Feldkirch, Vorarlberg, Austria
Patients applied
Trial Officials
Heinz Drexel, MD
Principal Investigator
Vorarlberg Institut of Vascular Investigation and Treatment, Academic Teaching Hospital, Austria
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials